Diagnostic tests planned to select patients most likely to benefit from skin cancer immunotherapy
GenomeWeb – 3/8/10 – GlaxoSmithKline and Abbott Molecular announced last week that they will work together to develop and commercialize a diagnostic test to select patients for an investigational skin cancer immunotherapy.

CRI researcher’s cancer immunotherapeutics formulation remains stable, potent
PharmaLive – 3/8/10 – Cancer-fighting bacterial vaccines from Advaxis maintain potency after long periods of storage, company reports.

Potential vaccine for rare cancer found safe
AHN – 3/4/10 – Researchers in the Netherlands say they have demonstrated the safety of a possible vaccine against mesothelioma, a lung cancer linked to asbestos exposure.

HPV vaccines may reduce a wide range of genital diseases
NewsRx – 3/4/10 – Vaccines that prevent infection by the human papillomavirus may result in rapid reduction of HPV-associated diseases, including cervical, vulvar, and vaginal cancers.

No meeting on Provenge prostate cancer vaccine needed, says FDA
AP – 3/2/10 – Shares of biotechnology company Dendreon Corp. jumped Tuesday after federal regulators said they don't plan to hold a public meeting on the company's prostate cancer treatment, possibly leading to quicker approval for the drug.

First therapeutic cancer vaccine approvals in 2010 “realistic expectation”
GenEngNews – 3/1/10 – Biopharma industry wonks expect the first therapeutic cancer vaccine approval to be among key advances in 2010.

CRI researchers report new technology that reveals how the immune system “sees” cancer
CRI – 3/1/10 – CRI researchers have taken a major step forward in identifying what the immune system “sees” on cancer cells, opening up new targets for cancer immunotherapy

Vaccine extends life of metastatic prostate cancer patients
BiotechDaily – 2/24/10 – In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to trigger an immune system attack on prostate tumor cells lived considerably longer than patients who received a placebo vaccine.

CRI researchers detect an unexpected link between Hodgkin Lymphoma and reproductive germ cells
CRI – 2/24/10 – A new study by CRI scientists implicates genes active at the first stages of fetal development in the progression and spread of cancers.

CRI Young Philanthropists team up with Saks Fifth Avenue for spring event
CRI – 2/16/10 – The upcoming Spring Into Style benefit at Saks Fifth Avenue, organized by the CRI Young Philanthropists, fosters charitable giving and awareness among young professionals.

CRI announces new immune-related response criteria
CRI – 12/24/09 – An international collaboration of scientists from academia and industry have defined a new set of criteria that more accurately judges the therapeutic activity of immunological cancer treatments.

Patients respond to tumor-targeting drugs
USA Today – 12/11/09 – Drugs that target tumors are showing promise in advanced breast cancer.

Gene testing may improve cancer treatment
Web MD – 12/11/09 – Individualized care for ovarian cancer patients may stand to benefit from new genetic testing.

Spices may improve cancer treatment
US News – 12/11/09 – Pepper and turmeric contain compounds that have been shown to target tumor-promoting stem cells.

Breast cancer survivors may need to limit alcohol consumption
CNN – 12/10/09 – Breast cancer survivors who drank moderately had a higher risk of recurrence, a new study says.

Loneliness, isolation may impact cancer outcome
Time – 12/8/09 – The findings suggest that a cancer patient’s treatment should be a holistic approach.

Soy product, breast cancer link re-looked
CNN – 12/8/09 – In a new study, estrogen-rich soy products were shown to have a positive effect on breast cancer patients.

6-year decline in cancer deaths
BusinessWeek – 12/7/09 – The decline is attributable to early detection, decreases in smoking and improved treatments.

Cancer Research Institute profiled on Pathology.Org
CRI – 11/18/09 – Pathology.org, a Web site sharing health information on a range of subjects, has profiled CRI

Mammograms not recommended between ages 40 and 50
ABC News – 11/18/09 – The United States Preventative Services Task Force is butting heads with doctors and organizations, like the American Cancer Society, on screening for breast cancer.

Cancer is not so genetically easy to define
New York Times – 11/18/09 – An Icelandic human genome researcher has discovered that major diseases do not have a simple genetic pattern.

Ghostwriting and the manipulation of scientific literature
New York Times – 11/18/09 – A senator asks medical schools to explain their ghostwriting practices, a process that could be considered to some as plagiarism.

Targeting normal cells in or near tumors slows cancer growth
The Wistar Institute – 11/16/09 – CRI-funded researchers at The Wistar Institute show that taking the "soil" away from the cancer "seed" can slow its growth.

New Act passed to protect from genetic testing
New York Times – 11/16/09 – The Genetic Information Nondiscrimination Act will ban employers and insurers from using genetic testing to discriminate against an employee.

HDL cholesterol found to cut cancer risks
Bloomberg – 11/15/09 – The cholesterol that flushes clogged arteries also reduces the rate by which cancer develops.

Call for better, faster, and cheaper drug development
New York Times – 11/15/09 – Drug development is being relooked in order to save investors billions of dollars and years of development time.

Finding could reduce breast cancer metastasis
US News – 11/12/09 – Researchers have found a new target that may reduce the spread of breast cancer to the bone.

Gene therapy aims at cancer weakness
Science Blog – 11/12/09 – By inactivating a DNA repair gene, researchers have been able to take away certain tumor cells’ ability to repair themselves.

Spreading the news about clinical trials
ABC News – 11/10/09 – When the mainstream media picks up stories about new treatments for cancer, it has the potential to help more patients.

Breakthrough study - HPV vaccine
Cancer Research Institute – 11/9/09 – A breakthrough study reports complete and partial remissions after vaccinations.